×

Facilitating patient communication using branching logic in an outpatient oncology treatment regimen

  • US 9,779,631 B1
  • Filed: 02/27/2013
  • Issued: 10/03/2017
  • Est. Priority Date: 02/27/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for communicating with a patient on an outpatient oral oncology regimen, the method executed by one or more processors programmed to perform the method, the method comprising:

  • creating, by one or more processors, an initial contact guide to direct a patient interaction occurring at the beginning of the outpatient oral oncology regimen, wherein the initial contact guide includes one or more questions about the outpatient oral oncology regimen, one or more informational scripts providing information to the patient regarding the outpatient oral oncology regimen, and branching logic to determine which questions and informational scripts to present and an order in which questions and informational scripts are presented, wherein the one or more questions are selected from a plurality of questions which are filtered based at least in part on teratogenicity of the outpatient oral oncology regimen and at least some of the filtered plurality of questions are automatically answered, by the one or more processors, based on medical history data and treatment data for the patient from a medical history database and a treatment database, respectively, and wherein the one or more questions include at least one experimental question in a different format than an original format for a corresponding question to determine whether the different format improves patient compliance;

    using, by the one or more processors, the initial contact guide to conduct an initial contact with the patient by;

    (i) presenting a first initial contact question to the patient,(ii) receiving an initial contact answer from the patient wherein the initial contact answer is stored in a patient interaction database,(iii) using the branching logic of the initial contact guide to determine which initial contact guide questions and informational scripts to present based on the initial contact answer, and(iv) presenting one or more subsequent questions or informational scripts based on the determination of which initial contact guide questions and informational scripts to present based on the initial contact answer, wherein the initial contact with the patient is conducted by an automated representative;

    creating, by the one or more processors, a secondary contact guide to direct a patient interaction occurring a first period of time after the beginning of the outpatient oral oncology regimen, wherein the secondary contact guide includes one or more questions about the outpatient oral oncology regimen, one or more informational scripts providing information to the patient regarding the outpatient oral oncology regimen, and branching logic to determine which questions and informational scripts to present and an order in which questions and informational scripts are presented;

    using, by the one or more processors, the secondary contact guide to conduct a secondary contact with the patient by;

    (i) after the first period of time after the beginning of the outpatient oral oncology regimen, presenting a first secondary contact question to the patient,(ii) receiving a secondary contact answer from the patient wherein the secondary contact answer is stored in a patient interaction database,(iii) using the branching logic of the secondary contact guide to determine which secondary contact guide questions and informational scripts to present based on the secondary contact answer, and(iv) presenting one or more subsequent questions or informational scripts based on the determination of which secondary contact guide questions and informational scripts to present based on the secondary contact answer, wherein the secondary contact with the patient is conducted by the automated representative;

    preparing, by the one or more processors, a report based on one or more of the initial contact or secondary contact; and

    sending, by the one or more processors, the report to a third party including one or more of a prescriber of the outpatient oral oncology regimen, a government agency, or an insurance provider,wherein the report includes indications of one or more adverse effects caused by the outpatient oral oncology regimen.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×